CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Earnings (Loss)	Noncontrolling Interest (NCI)	Total
Beginning balance at Dec. 31, 2022	$ 61,618	$ 294,029	$ 2,217,410	$ (9,075)	$ 32,841	$ 2,596,823
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			514,312		663	514,975
Foreign currency translation adjustment				9,762	4,267	14,029
Unrealized gain on investments and other				419		419
Other		(817)			930	113
Distributions to NCI					(7,355)	(7,355)
Purchase of remaining NCI of subsidiary		(1,210)			(917)	(2,127)
Cash dividends			(68,238)			(68,238)
Issuance of shares under employee stock purchase plan	33	2,717				2,750
Issuance of shares under stock grant programs	821	14,485	22			15,328
Issuance of shares under deferred compensation plans	124	(124)
Repurchase of shares	(975)		(81,174)			(82,149)
Expense associated with share-based compensation arrangements		34,727				34,727
Accrued expense under deferred compensation plans		10,895				10,895
Ending balance at Dec. 30, 2023	61,621	354,702	2,582,332	1,106	30,429	3,030,190
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			414,560		5,413	419,973
Foreign currency translation adjustment				(16,428)	(3,441)	(19,869)
Unrealized gain on investments and other				11		11
Other		(242)				(242)
Distributions to NCI					(11,848)	(11,848)
Purchase of remaining NCI of subsidiary		8,400				8,400
Cash dividends			(80,782)			(80,782)
Issuance of shares under employee stock purchase plan	28	2,784				2,812
Issuance of shares under stock grant programs	380	5,923	77			6,380
Issuance of shares under deferred compensation plans	104	(104)
Repurchase of shares	(1,409)	(17,686)	(140,907)			(160,002)
Expense associated with share-based compensation arrangements		37,938				37,938
Accrued expense under deferred compensation plans		11,664				11,664
Ending balance at Dec. 28, 2024	60,724	403,379	2,775,280	(15,311)	20,553	3,244,625
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			294,792		1,617	296,409
Foreign currency translation adjustment				15,653	2,720	18,373
Unrealized gain on investments and other				1,222		1,222
Other		(3,663)				(3,663)
Distributions to NCI					(3,005)	(3,005)
Cash dividends			(82,350)			(82,350)
Issuance of shares under employee stock purchase plan	30	2,441				2,471
Issuance of shares under stock grant programs	223	3,156	270			3,649
Issuance of shares under deferred compensation plans	114	(114)
Repurchase of shares	(4,499)	(9,503)	(428,617)			(442,619)
Expense associated with share-based compensation arrangements		37,583				37,583
Accrued expense under deferred compensation plans		11,549				11,549
Ending balance at Dec. 27, 2025	$ 56,592	$ 444,828	$ 2,559,375	$ 1,564	$ 21,885	$ 3,084,244

UFP INDUSTRIES INC 10-K